Author Archives: Ben Comer

Specialty Drugs and Reimbursement

By Ben Comer | Published: January 21, 2013
To maximize return on investment, pharma must think strategically about reimbursement channels and how new specialty products will perform in one versus another. By 2018, the amount health insurers spend per person on specialty, or biologic drugs, will equal or surpass the amount spent on traditional products, according to a new report. With the emergence [...]
Posted in Biotech, Strategy | Tagged , , , | Leave a comment

Oncologists, in Detail

By Ben Comer | Published: January 11, 2013
On average, cancer docs in the US would much rather deal with pharma sales reps in person as opposed to online, and drug companies are hiring more reps to support a slew of newly approved oncologic drugs, even as reps in other therapeutic areas get pink slips. But external pressures are likely to further limit [...]
Posted in Advertising, Sales, healthcare, social media | Tagged , , , | Leave a comment

J.P. Morgan: Suits Take San Francisco

By Ben Comer | Published: January 10, 2013
The perennial fat got chewed during the first two days at J.P. Morgan’s annual healthcare conference – buy back stock or raise dividends? – and the usual suspects lurked, but newcomers like Walgreens and not-so-pharma companies like Life Technologies packed the presentation halls and corridors, demonstrating investor and general interest in new ideas, products and [...]
Posted in Biotech, Deals, Events, Global, R&D, Regulatory, Strategy, Technology, healthcare, leadership, pricing | Tagged | Leave a comment

Compliance and Legal Not Always Eye-to-Eye

By Ben Comer | Published: December 19, 2012
As the role and stature of the compliance officer grows, legacy senior management structures and hierarchies can accidentally pit lawyers against one another. What is strictly legal in the context of sales and marketing practices, working with government officials in global markets, and running and reporting on clinical programs, may not always be the [...]
Posted in Corporate Responsibility, Legal, Marketing, Regulatory, Sales, Strategy, compliance | Tagged , , , , | Leave a comment

New York Pharma Forum: Together We Stand

By Ben Comer | Published: December 13, 2012
Participants in the 23rd Annual NYPF General Assembly last Friday outlined the many challenges facing industry, and the importance of collaboration as a way to move forward.
Posted in Biotech, Events, People, R&D, Strategy, Technology, leadership | Tagged , , , , , , , , , , , | Leave a comment